Neutrophil Lymphocyte Ratio and Duration of Prior Anti-Angiogenic Therapy as Biomarkers in Metastatic RCC Receiving Immune Checkpoint Inhibitor Therapy

Journal for ImmunoTherapy of Cancer - United Kingdom
doi 10.1186/s40425-017-0287-5
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ

Related search

Immune Checkpoint Therapy and the Search for Predictive Biomarkers

Cancer Journal
Cancer ResearchOncology
2016English

Hypokalemic Paralysis Secondary to Immune Checkpoint Inhibitor Therapy

Case Reports in Oncological Medicine
Oncology
2017English

Role of Pretreatment Neutrophil-To-Lymphocyte Ratio and Platelet-To-Lymphocyte Ratio as Prognostic Predictors for Survival in Metastatic Bladder Cancer Patients Receiving Fist-Line Chemotherapy

Erciyes Medical Journal
Medicine
2019English

On the Mechanism of Anti-Cd39 Immune Checkpoint Therapy

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2020English

The Genomic Landscape of Merkel Cell Carcinoma and Clinicogenomic Biomarkers of Response to Immune Checkpoint Inhibitor Therapy

Clinical Cancer Research
Cancer ResearchOncology
2019English

Histopathologic Characterization of Myocarditis Associated With Immune Checkpoint Inhibitor Therapy

Archives of Pathology and Laboratory Medicine
MedicineForensic MedicinePathologyMedical Laboratory Technology
2020English

Prognostic Value of Neutrophil-To-Lymphocyte Ratio and Plateletto- Lymphocyte Ratio in Intensity Modulated Radiation Therapy for Nasopharyngeal Carcinoma

Oncotarget
Oncology
2018English

ACKR2 in Hematopoietic Precursors as a Checkpoint of Neutrophil Release and Anti-Metastatic Activity

Nature Communications
AstronomyGeneticsMolecular BiologyBiochemistryChemistryPhysics
2018English

Neutrophil to Lymphocyte Ratio, Platelet to Lymphocyte Ratio, and Risk of Thromboembolism in Patients With Lymphoma Receiving Chemotherapy

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy